Approval · Notice of Compliance 30848 · 2023
FIRAZYR: Notice of Compliance 30848
Issued May 26, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30848
- Date
- May 26, 2023
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to drug product specifications
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIRAZYR | Not yet assigned | — |
Medicinal ingredients
- ICATIBANT ACETATE 10 MG per ML